Showing results (1961-1970 of 1,996) with videos related to

Sort By:
Pageof 200
The Lancet. Neurology|May 20, 2024
Specialist physiotherapy for functional motor disorder in England and Scotland (Physio4FMD): a pragmatic, multicentre, phase 3 randomised controlled trialGlenn Nielsen, Jon Stone, Teresa C Lee, et al.
The Lancet. Neurology|May 23, 2024
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialMichael Benatar, Thomas Hansen, Dror Rom, et al.
The Lancet. Neurology|November 17, 2023
Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort studyElianet Fonseca, Jose M Cabrera-Maqueda, Raquel Ruiz-García, et al.
The Lancet. Neurology|October 15, 2023
Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trialsRustam Al-Shahi Salman, Jacqueline Stephen, Jayne F Tierney, et al.
The Lancet. Neurology|September 22, 2023
Safety and efficacy of tamoxifen in boys with Duchenne muscular dystrophy (TAMDMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialBettina C Henzi, Simone Schmidt, Sara Nagy, et al.
The Lancet. Neurology|September 22, 2023
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trialAnthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.
The Lancet. Neurology|September 20, 2024
Differential diagnosis of suspected multiple sclerosis: global health considerationsJorge Correale, Andrew J Solomon, Jeffrey A Cohen, et al.
The Lancet. Neurology|September 20, 2024
Differential diagnosis of suspected multiple sclerosis: considerations in people from minority ethnic and racial backgrounds in North America, northern Europe, and AustralasiaLilyana Amezcua, Dalia Rotstein, Afsaneh Shirani, et al.
The Lancet. Neurology|February 21, 2026
Advances in migraine preventionDaniele Martinelli, Roberto De Icco, Haidar M Al-Khazali, et al.
The Lancet. Neurology|November 22, 2024
Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort studyEmily K Schworer, Matthew D Zammit, Jiebiao Wang, et al.
Pageof 200